Pablo V Escribá Selected Research

Pablo V Escribá Research Topics

Disease

27	Neoplasms (Cancer) 05/2023 - 02/2005
9	Glioma (Gliomas) 01/2023 - 12/2011
6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2007
4	Obesity 09/2017 - 01/2006
4	Inflammation (Inflammations) 01/2017 - 01/2006
4	Lung Neoplasms (Lung Cancer) 08/2015 - 03/2010
4	Hypertension (High Blood Pressure) 06/2014 - 07/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 01/2021
2	Pain (Aches) 11/2021 - 01/2017
2	Fatigue 11/2021 - 11/2021
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2017 - 01/2017
1	Infections 10/2022
1	Chronic Disease (Chronic Diseases) 11/2021
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Triple Negative Breast Neoplasms 04/2019
1	Breast Neoplasms (Breast Cancer) 04/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Neuralgia (Stump Neuralgia) 09/2017
1	Stroke (Strokes) 09/2017
1	Contusions 01/2017
1	Necrosis 02/2016
1	Adult Form Polyglucosan Body Disease 10/2015
1	Glycogen Storage Disease Type IV (Andersen's Disease) 10/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015
1	Pathologic Processes 06/2014
1	Parkinson Disease (Parkinson's Disease) 06/2014
1	Sphingolipidoses (Sphingolipidosis) 05/2013
1	Body Weight (Weight, Body) 07/2008
1	Type 2 Diabetes Mellitus (MODY) 03/2007
1	Autoimmune Diseases (Autoimmune Disease) 01/2006
1	Mental Disorders (Mental Disorder) 08/2004

Drug/Important Bio-Agent (IBA)

15	Membrane LipidsIBA 01/2023 - 03/2007
13	LipidsIBA 01/2023 - 01/2006
10	Fatty Acids (Saturated Fatty Acids)IBA 04/2019 - 03/2007
8	AcidsIBA 01/2023 - 07/2005
8	2-hydroxyoleic acidIBA 01/2019 - 12/2011
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2007
5	Oleic Acid (Oleate)IBA 01/2017 - 07/2005
4	phosphatidylcholine-ceramide phosphocholine transferaseIBA 01/2023 - 12/2011
4	Olive OilIBA 08/2015 - 10/2005
4	2-hydroxy-9-cis-octadecenoic acidIBA 06/2014 - 02/2005
4	SphingomyelinsIBA 05/2013 - 12/2011
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2015
2	SphingolipidsIBA 01/2023 - 05/2013
2	hydroxytrioleinIBA 04/2019 - 08/2015
2	4-hexyloxyaniline (HOA)IBA 01/2017 - 08/2009
2	Therapeutic UsesIBA 05/2015 - 06/2014
2	Antineoplastic Agents (Antineoplastics)IBA 05/2013 - 10/2005
2	Temozolomide (Temodar)FDA LinkGeneric 10/2012 - 05/2012
2	Protein Kinase CIBA 03/2010 - 10/2005
1	SodiumIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	Adenosine Monophosphate (AMP)IBA 10/2022
1	Penicillins (Penicillin)FDA Link 10/2022
1	Gemcitabine FDA Link 08/2022
1	dihydroceramideIBA 04/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Docosahexaenoic AcidsIBA 09/2017
1	4,7,10,13,16,19-docosahexaenoic acid ethyl esterIBA 09/2017
1	AlbuminsIBA 01/2017
1	Ether (Diethyl Ether)IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	Peptides (Polypeptides)IBA 10/2015
1	GlycogenIBA 10/2015
1	Protein Kinases (Protein Kinase)IBA 08/2015
1	Mitogen-Activated Protein Kinase 3IBA 08/2015
1	TrioleinIBA 08/2015
1	LigandsIBA 06/2014
1	fas Receptor (CD95 Antigen)IBA 06/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2013
1	Lipid Bilayers (Lipid Bilayer)IBA 05/2013
1	Liposomes (Liposome)IBA 05/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013
1	Cyclin B1IBA 01/2012
1	PalmitatesIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2009
1	serpentine (alkaloid)IBA 07/2008
1	Guanosine Triphosphate (GTP)IBA 07/2008
1	Guanosine Diphosphate (GDP)IBA 07/2008
1	NucleotidesIBA 07/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2008
1	Monounsaturated Fatty AcidsIBA 08/2006
1	FatsIBA 07/2005
1	Antihypertensive Agents (Antihypertensives)IBA 07/2005

Therapy/Procedure

14	Therapeutics 05/2023 - 08/2004
1	Oral Administration 05/2012